Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center, shared a post on X:
“MLS-DC25 Co-chair Janakiraman Subramanian presents on Minimal Residual Disease (MRD) monitoring in lung cancer as a tool to identify patients who could benefit from escalation/de-escalation and growing number of trials using MRD monitoring.”
More posts featuring MLS-DC25.
